跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPPI - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
EPPI
Approved
STANDARD
EPPI
Centaur Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bc96af4a67fa56ce
Company
Centaur Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
bc96af4a67fa56ce
Drug Approval Philippines Name
EPPI
Product Name
EPPI
Registration Number
DRP-2134
Brand Name
EPPI
Generic Name
ESOMEPRAZOLE (AS MAGNESIUM TRIHYDRATE)
Dosage Form
Enteric Coated Tablet
Dosage Strength
20 mg
Manufacturer
Centaur Pharmaceuticals Pvt. Ltd.
Importer
Strangen Pharmaceuticals Pvt. Ltd.
Distributor
Strangen Pharmaceuticals Pvt. Ltd.
Company Detail Path
/organization/centaur-pharmaceuticals-pvt-ltd
Issuance Date
20 January 2023
Expiry Date
23 April 2028
Pharmacologic Category
PROTON PUMP INHIBITOR
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bc96af4a67fa56ce
Type
Standard
Back to Philippines FDA Approvals